Enliven Therapeutics, Inc.

ELVN · Nasdaq · SIC 2834: Pharmaceutical Preparations
95
SEC Filings

Business Summary

3 Item 1A. Risk Factors 22 Item 1B. Unresolved Staff Comments 85 Item 1C. Cybersecurity 85 Item 2. Properties 86 Item 3. Legal Proceedings 86 Item 4. Mine Safety Disclosures 86 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 87 Item 6. Reserved 87 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 88 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 99 Item 8. F...

Next Earnings

Q2 FY2026 — expected 2026-08-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionELVNdiscussed_in_filing Cybersecurity
topic_mentionELVNdiscussed_in_filing Cybersecurity
topic_mentionELVNdiscussed_in_filing Cybersecurity
topic_mentionELVNdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-032025-12-310001193125-26-088232EDGAR100K words
2025-03-132024-12-310000950170-25-038758EDGAR—
2024-03-142023-12-310000950170-24-031495EDGAR—
2023-02-102022-12-310001564590-23-001729EDGAR—
2022-03-152021-12-310001564590-22-010216EDGAR—
2021-03-052020-12-310001564590-21-011098EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-277619EDGAR78K words
2025-08-132025-06-300001193125-25-179845EDGAR—
2025-05-142025-03-310000950170-25-071412EDGAR—
2024-11-132024-09-300000950170-24-126332EDGAR—
2024-08-132024-06-300000950170-24-096239EDGAR—
2024-05-142024-03-310000950170-24-059573EDGAR—
2023-11-092023-09-300000950170-23-062080EDGAR—
2023-08-102023-06-300000950170-23-041349EDGAR—
2023-05-112023-03-310000950170-23-021262EDGAR—
2022-10-252022-09-300001564590-22-035098EDGAR—
2022-08-032022-06-300001564590-22-027795EDGAR—
2022-05-062022-03-310001564590-22-018458EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-030001193125-26-088195EDGAR2K words
2026-01-070001193125-26-005535EDGAR—
2025-12-110001193125-25-315196EDGAR—
2025-11-120001193125-25-277580EDGAR—
2025-08-130001193125-25-179837EDGAR—
2025-06-250001193125-25-146874EDGAR—
2025-06-160001193125-25-141085EDGAR—
2025-06-130001193125-25-140285EDGAR—
2025-05-140000950170-25-071387EDGAR—
2025-03-130000950170-25-038737EDGAR—

95 total filings indexed. 67 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001672619
TickerELVN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7571be468fd911e4a22d5c0c978f4d29598246693d36aa9b7926b7f6d0ebbfec
parent: 1444c50137e1cf64341df65dac3f14ba2cd25576a6d226390f4f46a98c5ef5f3
content hash: 204782056fd4435a8f7aa68a7ac00266e0c6a7799a61e5562e6c8740a778589b
signed: 2026-04-13T04:44:50.495Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf